Veterans benefit administration: Veteran readiness and employment (vr&e) longitudinal study

Abstract: The Veteran Readiness and Employment (VR&E) program assists Veterans and Service members who have service-connected disabilities and employment barriers to prepare for, obtain and maintain suitable employment. The comprehensive services and assistance provided by VR&E include vocational assessment, rehabilitation planning, employment assistance and other services necessary to support the employment and daily living goals of Veterans. Congress passed the Veterans’ Benefits Improvement Act in 2008 that improved and enhanced benefits for Veterans. A section of this legislation required the Department of Veterans Affairs (VA) to conduct a 20-year longitudinal study of Veterans who applied for and entered a plan of services in the VR&E program in fiscal (FY) 2010 (Cohort I), FY 2012 (Cohort II) and FY 2014 (Cohort III). Each cohort is followed annually for 20 years. The primary goal of the longitudinal study of the VR&E program is to determine the long-term post-program outcomes in four major areas: Employment, Income, Home Ownership, Use of Supplemental Programs | The VR&E Longitudinal Study analyses data from two sources: self-reported survey data collected annually from a representative sample of cohort members and administrative data. The results of the VR&E Longitudinal Study will be used to enhance the services VR&E provides Veterans.

Read the full article
Report a problem with this article

Related articles

  • More for Policy & Practice

    Temporal trends in opioid-related care and pain among Veterans at the end of life

    Abstract: Context: In response to the opioid crisis, federal guidelines were implemented, including the Veterans Health Administration's (VA) Opioid Safety Initiative in 2013. The impact of policies on patients near the end of life is unknown. Objective: Examine temporal trends in opioid prescribing, pain, and opioid overdoses among Veterans near the end of life. Methods: Retrospective, time series analysis of VA decedents between October 2009 and September 2018 whose next-of-kin participated in VA's Bereaved Family Survey (BFS). Using multivariate regression to adjust for sociodemographic and clinical covariates, we examined temporal trends in outpatient opioid prescribing, uncontrolled pain based on BFS report, and opioid overdose-related hospitalizations, in the last month of life, overall and by clinical diagnosis (cancer versus non-cancer). Results: Among 79,409 decedents, mean daily outpatient opioid dose in morphine milligram equivalents in the last month of life decreased from 4.6 mg in 2010 to 2.1 mg in 2018 (adjusted change -0.20 mg/year; P